Skip to main content

Table 1 Cost-effectiveness of antibiotic treatment strategies in the management of MRB infections

From: Multiresistant bacteria and current therapy - the economical side of the story

Influencing factor

Effect on cost driver

Ref.

Early adequate first-line antibiotic therapy

Shorter duration of therapy

 
 

Early transfer from ICU to normal ward

 
 

Shorter LOS

 
 

Less complications

[9–13]

IV-to-oral switch

Shorter i.v. therapy

 
 

Earlier discharge and outpatient treatment

[14–17]

Adjusted duration of therapy

Less adverse events

 
 

Less selection of resistance

 
 

Less drug cost

 
 

Shorter LOS

[18–22]

Adherence to guidelines

Shorter duration of therapy

 
 

Shorter LOS

 
 

Less complications

 
 

Less ICU admissions

 
 

Less HMV

[7, 24, 25]